Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00006682 · ClinicalTrials.gov registry record · Phase 2
Vinorelbine and Docetaxel in Treating Women With Metastatic Breast Cancer
A Phase 2 study, sponsored by Medstar Health Research Institute.
- Completed
- Registry status
- Phase 2
- Development phase
NCT00006682: Completed Phase 2 study, sponsored by Medstar Health Research Institute.
NCT00006682 is a Phase 2 study that has completed, run by Medstar Health Research Institute. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00006682, a Phase 2 study, has completed, sponsored by Medstar Health Research Institute.
- COMPLETED
- Registry status
- Phase 2
- Development phase
Study Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of vinorelbine combined with docetaxel in treating women who have metastatic breast cancer.
Interventions
- DRUG docetaxel
- DRUG vinorelbine ditartrate
Trial Details
| Field | Value |
|---|---|
| Start Date | 2000-02 |
| Est. Completion | 2002-01-22 |
| Phase | Phase 2 |
What the finished NCT00006682 record still lists
NCT00006682 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 2 interventions - of which docetaxel is the first listed.
NCT00006682 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00006682 about?
NCT00006682 is a clinical study titled "Vinorelbine and Docetaxel in Treating Women With Metastatic Breast Cancer". RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of vinorelbine combined with docetaxel in treating women who have metast...
What is the current status of trial NCT00006682?
This trial is currently completed. It is a Phase 2 study. The study started on 2000-02. Estimated completion is 2002-01-22.
What interventions are being tested in trial NCT00006682?
The interventions under investigation include: docetaxel (DRUG), vinorelbine ditartrate (DRUG).
Who is sponsoring clinical trial NCT00006682?
This trial is sponsored by Medstar Health Research Institute, which has 115 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia